Summary
Latest filing:
James F. Oliviero III is Director of Nuvectis Pharma, Inc. (NVCT). 3 SEC Form 4 filings on record going back to 2024, most recently on 12 June 2026. Most recent open-market trade: sold $744K of CKPT on 20 December 2024. Lifetime open-market sales: $3.07M.
Recent Transactions
5Every recent SEC Form 4 transaction James F. Oliviero III has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James F. Oliviero III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marlio Charles Mosseri - $1.87M of NVCT open-market activity in the last 12 months
- Ron Bentsur - $279K of NVCT open-market activity in the last 12 months
- Juan Sanchez - $75K of NVCT open-market activity in the last 12 months
- Matthew L. Kaplan - $64K of NVCT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James F. Oliviero III?
James F. Oliviero III is a corporate insider, tracked as Director of Nuvectis Pharma, Inc. (NVCT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James F. Oliviero III last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 3 filings going back to 2024.
Has James F. Oliviero III been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($3.07M) across all tracked filings.
Where can I see all of James F. Oliviero III's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James F. Oliviero III and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
